ISI Group Initiates HCP With Neutral

Analysts at ISI Group initiated coverage on HCP

with a Neutral rating. The target price for HCP is set to $42. HCP shares have gained 2.69% over the past 52 weeks, while the S&P 500 index has surged 16.41% in the same period. HCP's shares rose 0.50% to close at $40.10 on Friday.